Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Mostra altre versioni (2)

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increa...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Brueggemann, A, Pai, R, Crook, D, Beall, B
Natura:	Journal article
Lingua:	English
Pubblicazione:	2007

Documenti analoghi

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
di: Brueggemann, A, et al.
Pubblicazione: (2007)

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
di: Brueggemann, AB, et al.
Pubblicazione: (2007)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
di: Golubchik, T, et al.
Pubblicazione: (2012)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
di: Golubchik, T, et al.
Pubblicazione: (2012)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.
di: Croucher, N, et al.
Pubblicazione: (2014)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
di: Andrew D. Wiese, et al.
Pubblicazione: (2019-04-01)

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
di: Obando, I, et al.
Pubblicazione: (2007)

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
di: Adam L Cohen, et al.
Pubblicazione: (2012-01-01)

Pneumococcal Vaccination in the United States: Current Recommendations and Strategies to Improve Vaccination Coverage
di: Cynthia G Whitney
Pubblicazione: (1999-01-01)

State of pneumococcal vaccine immunity
di: Mustafa Akkoyunlu
Pubblicazione: (2024-12-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
di: Sandra S. Richter, et al.
Pubblicazione: (2013-07-01)

Pneumococcal Vaccines
di: D. E. Briles, et al.
Pubblicazione: (2019-12-01)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
di: Foster, D, et al.
Pubblicazione: (2008)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
di: Zhang Jian Shayne F, et al.
Pubblicazione: (2011-04-01)

Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
di: Salini Mohanty, et al.
Pubblicazione: (2025-12-01)

Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
di: Salini Mohanty, et al.
Pubblicazione: (2024-12-01)

Emerging vaccine strategies against the incessant pneumococcal disease
di: Jeremy A. Duke, et al.
Pubblicazione: (2023-08-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
di: Hiroaki Takeda, et al.
Pubblicazione: (2019-01-01)

Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States
di: Omotola Olasupo, et al.
Pubblicazione: (2020-01-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
di: Sleeman, K, et al.
Pubblicazione: (2001)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
di: Thijs W. Hoffman, MD, et al.
Pubblicazione: (2020-06-01)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
di: Licciardi, P, et al.
Pubblicazione: (2016)

Generalized granuloma annulare after pneumococcal vaccination,
di: Miguel Fernando García-Gil, et al.
Pubblicazione: (2021-03-01)

Pneumococcal vaccination in developing countries.
di: Levine, O, et al.
Pubblicazione: (2006)

Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
di: Salini Mohanty, et al.
Pubblicazione: (2024-12-01)

Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].
di: Marisol Figueira, et al.
Pubblicazione: (2014-01-01)

Pneumococcal vaccines in China
di: Shanshan Wang, et al.
Pubblicazione: (2025-12-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
di: Nobuhiro Asai, et al.
Pubblicazione: (2021-11-01)

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
di: Van Effelterre, T, et al.
Pubblicazione: (2010)

Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care Providers
di: Patricia Sacco, et al.
Pubblicazione: (2019-09-01)

Vaccination of Icelandic children with the 10-valent pneumococcal vaccine leads to a significant herd effect among adults in Iceland
di: Quirk, S, et al.
Pubblicazione: (2019)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
di: Anita H J van den Biggelaar, et al.
Pubblicazione: (2017-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
di: Carina Valente, et al.
Pubblicazione: (2012-01-01)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
di: Shamez N. Ladhani, et al.
Pubblicazione: (2013-01-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
di: Brueggemann, A, et al.
Pubblicazione: (2013)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
di: Victor Morais, et al.
Pubblicazione: (2022-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
di: N. L. Chernaya, et al.
Pubblicazione: (2013-01-01)

State of the globe: Effect of pneumococcal conjugate vaccines on nonvaccine-type invasive pneumococcal disease
di: Sunil Kumar Raina
Pubblicazione: (2019-01-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
di: Brueggemann, AB, et al.
Pubblicazione: (2013)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
di: Ahmet Arvas, et al.
Pubblicazione: (2017-08-01)